Investing in Abcam PLC Sponsored ADR (ABCM)

Valuation methodValue, $Upside, %
Artificial intelligence (AI)2.08-91
Intrinsic value (DCF)2.08-91
Graham-Dodd Method0.31-99
Graham Formula0.00-100

Company description

Abcam Plc is a global life science company, which distributes antibodies and associated protein research tools. Its product includes primary and secondary antibodies, proteins, peptides, lysates, biochemicals, immunoassays, and other kits. The company was founded by David Douglas Cleevely, Anthony Kouzarides, and Jonathan Simon Milner on February 12, 1998 and is headquartered in Cambridge, the United Kingdom.